Login / Signup

Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.

Megen C WittlingHannah M KnochelmannMegan M WyattGuillermo O Rangel RiveraAnna C ColeGregory B LesinskiChrystal M Paulos
Published in: Journal for immunotherapy of cancer (2024)
based T-cell therapies are now emerging in the clinic.
Keyphrases
  • induced apoptosis
  • cell cycle arrest
  • primary care
  • cerebral ischemia
  • cell proliferation
  • brain injury